(lp0
S'The Prudential Financial Inc. Acquires 1250 Shares of Alkermes PLC  Petro Global News 24 - Feb 6, 2017 A number of other hedge funds and other institutional investors have also modified their holdings of ALKS. Sei Investments Co. boosted its position in shares of Alkermes PLC by 1,223.7% in the third quarter. Sei Investments Co. now owns 88,225 shares ...'
p1
aS"Stocks: The Alkermes PLC  SVP Sells $567652.65 in Stock Petro Global News 24 - Jan 7, 2017 Alkermes PLC  opened at 59.64 on Friday. The firm's 50-day moving average price is $56.95 and its 200-day moving average price is $50.26."
p2
aS"Alkermes Plc  Q4 2016 Results - Earnings Call Transcript Seeking Alpha - Feb 15, 2017 Good morning, and welcome to the Alkermes' Fourth Quarter and Year End 2016 Financial Results. My name is Brandon, and I'll be your operator for today.Alkermes plc  Tops Q4 EPS by 11c - StreetInsider.comFederated Investors Inc. PA Holds Stake in Alkermes PLC  - The Cerbat Gem"
p3
aS'Alkermes PLC: Sales Rise, Losses Fall, and the Pipeline Moves Forward Motley Fool - Nov 7, 2016 Alkermes , a biopharmaceutical company that specializes in extended-release drug delivery technology, reported third-quarter results on Nov. 2 and provided investors with an update on its pipeline.'
p4
aS"Why Alkermes PLC Skyrocketed Today Motley Fool - Oct 21, 2016 Alkermes tested ALKS 5461 in patients with major depressive disorder who haven't been helped by other drugs. At the higher dose, ALKS 5461 improved symptoms of depression -- based on two different scales used by doctors -- compared with placebo.Analysts Change Price Targets for Two Biotech Stocks: Alkermes Plc (ALKS ... - Smarter AnalystAlkermes Surge by a Record 47% on Depression Pill Trial Success - Bloomberg"
p5
aS'Investors Are Missing An Opportunity With Alkermes Seeking Alpha - Feb 27, 2017 We remain bullish on Alkermes  because of their substantial and growing revenue and their healthy pipeline of valuable assets.'
p6
aS'Alkermes plc  to Present Data on Two-Month Dosing Option of ARISTADA at ... StreetInsider.com - Mar 20, 2017 Alkermes plc  today announced that data for the two-month dosing option of ARISTADA  extended-release injectable suspension for the treatment of schizophrenia will be presented at the 16th International Congress&nbsp;...'
p7
aS'-$0.24 Earnings Per Share Expected for Alkermes Plc  This Quarter The Cerbat Gem - Apr 16, 2017 Alkermes Plc logo Analysts forecast that Alkermes Plc  will announce earnings per share of  for the current quarter, Zacks Investment Research reports.Street Session Update on Alkermes plc  - Rockville RegisterAlkermes Plc  Insider Sells $361860.30 in Stock - BBNS'
p8
aS'PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union ... Nasdaq - Feb 14, 2017 PRIMECAP Management added to the holdings in Alkermes PLC by 102.19%. The purchase prices were between $42.3 and $59.5, with an estimated average price of $53.46.'
p9
aS'Trading Levels in Focus: Alkermes Plc  Piedmont Register - 13 hours ago Alkermes Plc  has a current 14-day RSI reading of 44.48, the 7-day is 36.77, and the 3-day is 25.02. The RSI, or Relative Strength Index is a popular oscillating indicator among traders and investors.'
p10
a.